XCUR: Exicure, Inc. Stock

by  •  • Comments Off on XCUR: Exicure, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 34.71
Enterprise Value ($M) 34.36
Book Value ($M) 1.54
Book Value / Share 0.51
Price / Book 22.46
NCAV ($M) -6.49
NCAV / Share -2.13
Price / NCAV -5.35

Profitability (mra)
Return on Invested Capital (ROIC) -0.43
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.71
Current Ratio 0.71

Balance Sheet (mrq) ($M)
Current Assets 2.60
Assets 10.63
Liabilities 9.09
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
12-23 13G Sangsangin Investment & Securities Co., Ltd. 14.30
11-29 13D HiTron Systems Inc. 16.60
09-16 13D/A CBI USA, Inc. 39.10 -72.25

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-06-17 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-06-06 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 2
2024-06-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-06-06 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 2
2024-05-16 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-16 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1
2024-05-16 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 7,344 42,134 17.43
2025-03-06 38,907 136,613 28.48
2025-03-05 28,956 116,112 24.94
2025-03-04 66,659 221,832 30.05

(click for more detail)

Similar Companies
VYNE – VYNE Therapeutics Inc. WINT – Windtree Therapeutics, Inc.
XBIO – Xenetic Biosciences, Inc. XFOR – X4 Pharmaceuticals, Inc.
ZURA – Zura Bio Limited


Financial data and stock pages provided by
Fintel.io